The menopause – and the years main up to it – can have an effect on girls’s day by day life in many various methods.
Falling ranges of oestrogen within the physique have a knock-on impact on the mind, on durations, pores and skin, muscle tissues and feelings.
Hot flushes and evening sweats are a number of the most typical signs skilled. They can disturb sleep and focus, whereas additionally affecting relationships and the power to work.
Hormone alternative remedy (HRT) is on the market to deal with signs within the type of tablets, patches and gels – however there have been few non-hormonal choices accessible to date.
Veoza, also called fezolinetant, is a vital further choice, says Helen Knight, director of medicines analysis at NICE – the National Institute for Health and Care Excellence – which supplies steering on how to enhance healthcare.
“For those who are unable to take HRT for varying reasons, options have historically been limited, and we have heard clearly from patients how difficult that can be,” she mentioned.
“The evidence shows fezolinetant can meaningfully reduce symptoms, and was found to be cost effective, offering value for the taxpayer.
“This resolution will give much-needed aid to these for whom HRT is unsuitable.”
The daily pill Veoza was approved in 2023 – however has solely now been really useful for treating average to extreme signs of menopausal hot flushes and evening sweats on the NHS, by NICE., external
The decision applies in England. Wales and Northern Ireland often follow the same NICE guidance, while Scotland has its own body that makes decisions on new drugs.
HRT remains to be the first-line remedy choice, NICE says, due to its clear advantages and the vary of various varieties accessible, and it is thought most girls will proceed to take it.
